Nov 8, 2023 4:05pm EST Matinas BioPharma Reports Third Quarter 2023 Financial Results and Provides a Business Update
Nov 7, 2023 7:30am EST Matinas BioPharma Announces Positive in vivo Efficacy Results of Oral LNC Docetaxel Formulation in a Melanoma Model
